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Background
Most cancer cells down-regulate gap junctions (GJ)
resulting in loss of communication with their surround-
ing microenvironment. We have previously shown that
infection of mouse tumour cell lines with Salmonella
induces the up-regulation of connexin 43 (Cx43), a ubi-
quitous protein that forms GJs. This up-regulation
allows the transfer of antigens between tumour cells and
dendritic cells (DC) licensing them to induce an efficient
anti-tumour response in a mouse model of melanoma
(Saccheri et al., Sci TM 2010).
Herein, we tested the idea that through the formation
of intercellular communication channels in tumour cells,
human autologous dendritic cells could be loaded with
tumour antigens, preprocessed by cancer cells, and could
be used to generate a cancer vaccine.
Material and methods
Human melanoma cell lines were infected with a vaccine
strain of Salmonella Ty21a (Vivotif) to induce up-regulation
of Cx43 and formation of GJ channels. HLA matched DCs
were differentiated in vitro by peripheral blood purified
monocytes from healthy donors. Expression of surface
molecules, cytokine release and cell proliferation was deter-
mined by cytofluorimetry. Cytotoxicity was determined
either by Delfia cell cytotoxicity assay (PerkinElmer) and by
a cytofluorimetry based CD107 assay.
Results
Vivotif-infected tumor cells established GJs in human
melanoma cell lines. We show that tumour derived anti-
gens could transit from ‘donor’ melanoma cells’ cytoplasm
to DC’s cytoplasm through GJs, generate a tumour-specific
CTL response and reactivate tumour infiltrating lympho-
cyte (TIL) in vitro. The transfer of tumor antigens was
GJ-dependent because it was abolished in the presence of
a GJ-specific inhibitor. In vitro generated tumour-specific
human CTLs lysed also non-donor melanoma cell lines
indicating that DCs were loaded with tumour-associated
antigens shared among melanoma cell lines.
Moreover, in vitro generated CTLs were melanoma
specific because they were unable to lyse HLA matched
colorectal adenocarcinoma cell lines.
Conclusions
We exploited an antimicrobial response present in tumour
cells to activate cytotoxic CD8 T cells specific for tumour-
peptides, through a new pathway of antigen loading of
human dendritic cells via intercellular communication
channels. This unique and novel approach can be applied
across a wide range of tumour cell types and can be used
clinically as therapeutic vaccine alone or in combination
with gold standard treatments.
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